Johnson Pharma

{
  "main_header": {
    "sid": 233635,
    "name": "Johnson Pharma",
    "stock_name": "Johnson Pharma",
    "full_name": "Johnson Pharmacare Ltd",
    "name_url": "stocks-analysis/johnson-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.45",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.45",
    "mcapval": "24.75 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532154,
    "symbol": "",
    "ind_name": "Diversified Commercial Services",
    "ind_code": 49,
    "sector_id": 17,
    "indexname": "India SENSEX",
    "isin": "INE560F01022",
    "curr_date": "Sep 23, 03:28 PM",
    "curr_time": "15:29 PM",
    "last_traded_at": "Sep 23, 03:28 PM IST",
    "bse_nse_vol": "8.42 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 23, 2026",
    "traded_date_str": "2026 09 23",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/johnson-pharma-233635-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Johnson Pharmacare Ltd Falls to 52-Week Low of Rs 0.43 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-pharmacare-ltd-falls-to-52-week-low-of-rs043-amidst-weak-financial-metrics-4201431",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JohnsonPharmaca_priceRelatedfactors_4201431.png",
        "date": "2026-09-22 12:35:50",
        "description": "A sharp decline has pushed Johnson Pharmacare Ltd to a fresh 52-week low of Rs 0.43 on 22 Sep 2026, marking a 41.56% drop over the past year and signalling intensified selling pressure amid deteriorating fundamentals."
      },
      {
        "title": "Markets Rally, But Johnson Pharmacare Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-pharmacare-ltd-falls-to-52-week-low-of-rs045-4153691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JohnsonPharmaca_priceRelatedfactors_4153691.png",
        "date": "2026-08-14 11:11:11",
        "description": ""
      },
      {
        "title": "Are Johnson Pharmacare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-johnson-pharmacare-ltd-latest-results-good-or-bad-4152293",
        "imagepath": "",
        "date": "2026-08-13 19:44:02",
        "description": "Johnson Pharmacare Ltd's latest financial results for Q4 FY26 reveal a concerning operational and financial situation. The company reported a net loss of ₹55.61 crores, marking a significant decline from a marginal loss of ₹0.51 crores in the same quarter last year. This represents a substantial deterioration in profitability, with the company experiencing zero revenue for the seventh consecutive quarter, indicating a complete operational standstill.\n\nThe operating loss for the quarter was ₹42.70 crores, which is a stark contrast to the previous year's negligible loss, highlighting severe operational challenges. The company's return on equity (ROE) has plummeted to an alarming -4,146.00%, reflecting extreme capital erosion and operational inefficiency. Furthermore, the book value stands at ₹1.02, with a price-to-book value ratio of 29.15x, suggesting a significant overvaluation relative to its financial per..."
      },
      {
        "title": "Johnson Pharmacare Ltd Falls to 52-Week Low of Rs 0.46 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-pharmacare-ltd-falls-to-52-week-low-of-rs046-amidst-weak-financial-metrics-4118144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JohnsonPharmaca_priceRelatedfactors_4118144.png",
        "date": "2026-07-23 15:10:25",
        "description": "For the second consecutive session, Johnson Pharmacare Ltd has declined further, hitting a fresh 52-week low of Rs 0.46 on 23 Jul 2026, marking a significant 44.7% drop over the past year and underscoring persistent downward pressure on this micro-cap stock."
      },
      {
        "title": "Johnson Pharmacare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/johnson-pharmacare-ltd-is-rated-strong-sell-4096260",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JohnsonPharmaca_mojoScore_4096260.png",
        "date": "2026-07-10 10:10:51",
        "description": "Johnson Pharmacare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 29 May 2026, reflecting a comprehensive assessment of the company’s current position. However, all fundamentals, returns, and financial metrics discussed below are as of 10 July 2026, providing investors with the latest insights into the stock’s performance and outlook."
      }
    ],
    "total": 89,
    "sid": "233635",
    "stock_news_url": "https://www.marketsmojo.com/news/johnson-pharmacare-233635"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Aug-2026",
      "details": "Pursuant to regulation 47 of LODR 2015 -Submission of extract of Newspaper Publication for the unaudited financial result for the quarter ended 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Un-Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter Ended On June 30Th 2026 And Along With Limited Review Report Thereon.",
      "datetime": "13-Aug-2026",
      "details": "Submission of Un-Audited Financial Results for the Quarter ended on June 30th 2026 and along with Limited Review Report Thereon.",
      "source": "BSE"
    },
    {
      "caption": "Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On June 30Th 2026.",
      "datetime": "13-Aug-2026",
      "details": "Undertaking for non - applicability of reg 32 of sebi (lodr) reg 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> stock split, ex-date: 05 Jan 22",
          "dt": "2022-01-05",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 07 Apr 22",
          "dt": "2022-04-07",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Johnson Pharmacare Ltd Falls to 52-Week Low of Rs 0.43 as Sell-Off Deepens

2026-09-22 12:35:50

A sharp decline has pushed Johnson Pharmacare Ltd to a fresh 52-week low of Rs 0.43 on 22 Sep 2026, marking a 41.56% drop over the past year and signalling intensified selling pressure amid deteriorating fundamentals.

Read full news article

Markets Rally, But Johnson Pharmacare Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-08-14 11:11:11

Read full news article

Are Johnson Pharmacare Ltd latest results good or bad?

2026-08-13 19:44:02

Johnson Pharmacare Ltd's latest financial results for Q4 FY26 reveal a concerning operational and financial situation. The company reported a net loss of ₹55.61 crores, marking a significant decline from a marginal loss of ₹0.51 crores in the same quarter last year. This represents a substantial deterioration in profitability, with the company experiencing zero revenue for the seventh consecutive quarter, indicating a complete operational standstill. The operating loss for the quarter was ₹42.70 crores, which is a stark contrast to the previous year's negligible loss, highlighting severe operational challenges. The company's return on equity (ROE) has plummeted to an alarming -4,146.00%, reflecting extreme capital erosion and operational inefficiency. Furthermore, the book value stands at ₹1.02, with a price-to-book value ratio of 29.15x, suggesting a significant overvaluation relative to its financial per...

Read full news article

Johnson Pharmacare Ltd Falls to 52-Week Low of Rs 0.46 as Sell-Off Deepens

2026-07-23 15:10:25

For the second consecutive session, Johnson Pharmacare Ltd has declined further, hitting a fresh 52-week low of Rs 0.46 on 23 Jul 2026, marking a significant 44.7% drop over the past year and underscoring persistent downward pressure on this micro-cap stock.

Read full news article

Johnson Pharmacare Ltd is Rated Strong Sell

2026-07-10 10:10:51

Johnson Pharmacare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 29 May 2026, reflecting a comprehensive assessment of the company’s current position. However, all fundamentals, returns, and financial metrics discussed below are as of 10 July 2026, providing investors with the latest insights into the stock’s performance and outlook.

Read full news article

View All News